Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SynaptixBio Ltd. logo — Developing therapies for severe leukodystrophies

SynaptixBio Ltd.

Developing therapies for severe leukodystrophies

Founded 2021 United Kingdom Oxford, United Kingdom 5 employees

General Information

Company Name SynaptixBio Ltd.
Founded Year 2021
Location United Kingdom Oxford, United Kingdom +1
Employees 5
Social

Get notified when SynaptixBio Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SynaptixBio Ltd.

Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases.    SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system.

No funding data available for SynaptixBio Ltd. yet.

Get notified when SynaptixBio Ltd. raises funding

SynaptixBio Ltd. Alternatives & Competitors

SynaptixBio Ltd. vs
Taysha Gene Therapies
Taysha Gene Therapies United States

Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogenic diseases...

IPO
134 employees
Biotechnology, Life Sciences
SynaptixBio Ltd. vs
Genecure
Genecure

Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and can...

Series Unknown
Biotechnology, Health Care
SynaptixBio Ltd. vs
uniQure
uniQure The Netherlands

Transforming the lives of patients through gene therapy

IPO
309 employees
Biotechnology, Pharmaceutical

FAQ About SynaptixBio Ltd.

Developing therapies for severe leukodystrophies
SynaptixBio Ltd. was founded in 2021.
SynaptixBio Ltd. is headquartered in Oxford, United Kingdom.
SynaptixBio Ltd. has approximately 5 employees.
Top alternatives and competitors to SynaptixBio Ltd. include Taysha Gene Therapies, Genecure, uniQure, Atalanta Therapeutics, Orchard Therapeutics - U.S.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SynaptixBio Ltd. and Taysha Gene Therapies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SynaptixBio Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy